Four DEGs are involved in the p53 signaling pathway, that has been associated with lymphopenia in severe COVID-19 patients3, and three with the Hippo pathway, recently associated with the antiviral host response in COVID-19112. This evidence concerns the gene TP53 and lymphopenia.